Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Ancillary Symposia 2016:

Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options

Browse by: Sort by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5 from Ancillary Symposia 2016
Welcome and Introduction
Bernard Zinman
University of Toronto, Toronto, ON
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
Cardiovascular Risk Screening and Prevention: Who, When, How Often, What Medication?
Naveed Sattar, PhD, FRCP, FRCPath
University of Glasgow, Glasgow, United Kingdom
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
Cardiovascular Effects of Medications for Glycemic Control: Evidence from Large Outcomes Trials
Hertzel C Gerstein, MD,MSc,FRCPC
McMaster University, Hamilton, ON
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
SGLT-2 Inhibitors - Cardiovascular Impact and Safety Concerns
Silvio E Inzucchi, MD
Yale School of Medicine, New Haven, CT
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
Panel Discussion and Audience Questions
Bernard Zinman
University of Toronto, Toronto, ON
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5 from Ancillary Symposia 2016